New WHO Public Inspection Report (WHOPIR) published
M
Second generic sofosbuvir prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Second generic praziquantel prequalified
M
WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
Global public consultation on WHO prequalification of similar biotherapeutic products
M
In October this year WHO will launch a pilot project for prequalifying biosimilar medicines, a step towards making some of the most expensive treatments for cancer more widely available in lo
Newly prequalified Active Pharmaceutical Ingredient (API)
M
Isoniazid (WHOAPI-005) manufactured by Amsal Chem Pvt Ltd has been prequalified by the WHO Prequalification Team: medicines under its active pharmaceutical ingredient (API) prequalification procedu
First paediatric isoniazid/rifampicin 50/75 dispersible tablet prequalified
M
On 31 August 2017, WHO Prequalification Team - Medicines (PQTm) added the below new product to its prequalified list:
WHO Prequalifies key treatment for children with TB
M
WHO has just prequalified a two-pills-in-one paediatric medicine that is critical for the continuation phase of the six-month treatment required to cure tuberculosis (TB).